Author: Office Manager
U.S. News | One-Dose Blood Thinner Could Slash Blood Clot Risk After Knee Replacement

TUESDAY, July 20, 2021 (HealthDay News) — Anyone who’s ever undergone knee replacement understands the real and troubling risk of post-op blood clots. Many patients are told take a daily blood thinner pill long after their procedure. But a new study finds that a one-time injection of an experimental blood thinner called abelacimab may greatly […]

MJBiz Daily | Online cannabis sales boom amid COVID-19 spurs delivery-service acquisitions

The explosive growth of e-commerce during the COVID-19 pandemic has propelled new interest in acquisitions involving direct-to-consumer cannabis delivery. Some marijuana companies have acquired delivery-only cannabis dispensaries, while others have spent more to acquire vertically integrated MJ firms with home-delivery operations included.

HCP Live | Abelacimab Effective in Prevention of VTE, Including Low Bleeding Risk

Data has shown the effectiveness of factor XI in postoperative venous thromboembolism (VTE) is still unknown, particularly when compared to preoperative inhibition. A recent phase 2 study compared the efficacy and safety of abelcaimab administered postoperative in comparison to the efficacy and safety of enoxaparin in patients undergoing total knee arthroplasty.